Press Releases
WASHINGTON – U.S. Rep. Diana DeGette (CO-1) issued the following statement following House passage of H.R. 2560. The bill, which would require passage of a constitutional amendment out of both the House and Senate prior to raising the debt ceiling, includes cuts even steeper than the devastating Ryan budget and caps federal outlays at levels not seen since 1966.
WASHINGTON – Today, U.S. Rep. Diana DeGette (CO-1) issued the following statement in response to the Institute of Medicine (IOM) report on additional preventive health services that should be covered and provided to women at no cost, under insurance plans created by the Affordable Care Act.
WASHINGTON, DC - U.S. Rep. Diana DeGette (CO-1) submitted the following comments yesterday to the U.S. Forest Service in response to their proposed Colorado Roadless Rule. The Forest Service is considering a state-specific rule to manage inventoried roadless areas on national forest lands in Colorado, rather than complying with the national rule.
ENGLEWOOD – U.S. Rep. Diana DeGette (CO-1) today marked the introduction of the Stem Cell Research Advancement Act of 2011 with a visit to the world-renowned Craig Hospital, where she toured the Top Ten rehabilitation facility and met with hospital leadership, staff, and their patients.
WASHINGTON – U.S. Reps. Diana DeGette (D-CO) and Charlie Dent (R-PA) introduced the bipartisan Stem Cell Research Advancement Act, to ensure a lasting framework overseeing ethical stem cell research at the National Institutes of Health (NIH), and finally bring certainty to the scientific community pursuing life-saving cures and treatments.
"I commend President Obama for honoring his commitment to begin troop withdrawals from Afghanistan, but I urge him to provide his long-term strategy for total withdrawal as soon as possible. U.S.
WASHINGTON – U.S. Reps. Diana DeGette (CO-01) and Tom Rooney (FL-16) today will introduce the "Preserving Access to Life-Saving Medications Act," a bipartisan bill to improve patient safety by reducing shortages of life-saving drugs.
WASHINGTON, DC – U.S. Representative Diana DeGette today joined with other key House Democrats to request that McKinsey & Company release methodology and other important information on their recent study on the Affordable Care Act and employer sponsored health care. Serious concerns have been raised about the accuracy of the study that conflicts with other nonpartisan studies on the issue.
WASHINGTON - Today, U.S. Rep. Diana DeGette voted against two House measures pertaining to U.S. involvement in Libya. She issued the following statement regarding her opposition: